Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
May activate or repress transcription via interactions with sequence specific DNA-binding proteins. Zusätzlich bieten wir Ihnen MYBBP1A Kits (3) und MYBBP1A Proteine (3) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 72 products:
Human Polyclonal MYBBP1A Primary Antibody für WB - ABIN1881560
Perrera, Colombo, Valsasina, Carpinelli, Troiani, Modugno, Gianellini, Cappella, Isacchi, Moll, Rusconi: Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinase. in The Journal of biological chemistry 2010
Show all 5 Pubmed References
Human Polyclonal MYBBP1A Primary Antibody für ICC, IF - ABIN253189
Nahálková, Tomkinson: TPPII, MYBBP1A and CDK2 form a protein-protein interaction network. in Archives of biochemistry and biophysics 2014
Guinea Pig Polyclonal MYBBP1A Primary Antibody für IHC, WB - ABIN2780004
Fan, Rhee, St-Pierre, Handschin, Puigserver, Lin, Jäeger, Erdjument-Bromage, Tempst, Spiegelman: Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK. in Genes & development 2004
Show all 2 Pubmed References
Mybbp1a is a novel negative regulator of Sirt7 (zeige SIRT7 Antikörper).
Data show that down-regulation of MYBBP1A decreases the growth rate of wild type mouse embryonic stem cells, embryo fibroblasts (MEFs) and of human HeLa cells, where it also promotes apoptosis.
Mybbp1a may play a dual role in the rRNA metabolism, potentially linking and coordinating ribosomal DNA transcription and pre-rRNA processing to allow for the efficient synthesis of ribosomes.
Myb-binding protein 1a was identified as a novel negative regulator of muscle-specific (zeige EIF3K Antikörper) gene expression and myoblast differentiation.
Myb (zeige MYB Antikörper)-binding protein p160 (zeige MSH6 Antikörper) is a novel target of the von Hippel-Lindau tumor suppressor.
Ipr1 (zeige SP110 Antikörper) might be involved in apoptosis pathway via MYBBP1A.
Myb-binding protein 1a augments AhR (zeige AHR Antikörper)-dependent gene expression
Mybbp1a is a nucleocytoplasmic shuttling protein involved in nuclear import and export via CRM1 (zeige XPO1 Antikörper)-dependent and -independent pathways.
These data show that p160 (zeige MSH6 Antikörper) is a novel regulator of Prep1-Pbx1 (zeige PBX1 Antikörper) transcriptional activity.
SRC-3 (zeige NCOA3 Antikörper) alone of the p160 (zeige MSH6 Antikörper) coactivators enhanced CAR transactivation in hepatic cells without PB treatment.
The results indicated that both the heterozygous genotype GC and homozygous genotype CC in rs3809849 in MYBBP1A had significant effects on the risk of pulmonary tuberculosis, and heterozygous genotype CT in rs9061 in SP110 (zeige SP110 Antikörper) also had similar effects.
We propose that the nucleolus functions as a stress sensor to modulate p53 (zeige TP53 Antikörper) protein levels and its acetylation status, determining cell fate between cell cycle arrest and apoptosis by regulating MYBBP1A translocation.
MYBBP1A(low)AKT (zeige AKT1 Antikörper)(Ser473)(high) staining pattern serves not only as a marker for the pre-senescent stage but also as an indicator of OPSCC patients at high risk for treatment failure.
TPPII (zeige Tpp2 Antikörper), MYBBP1A and CDK2 (zeige CDK2 Antikörper) form a protein-protein interaction network.
MYBBP1A functions to enhance p53 (zeige TP53 Antikörper) tetramerization that is necessary for p53 (zeige TP53 Antikörper) activation.
Regulators, including BCL11A (zeige BCL11A Antikörper), MYB (zeige MYB Antikörper), and KLF1 (zeige KLF1 Antikörper), hold great promise to develop targeted and more effective approaches for HbF induction.
MYBBP1A-p53 (zeige TP53 Antikörper) binding property can account for efficient p53 (zeige TP53 Antikörper)-activation by MYBBP1A under nucleolar stress. Our results support the idea that MYBBP1A plays catalytic roles in p53 (zeige TP53 Antikörper) acetylation and activation
Suggest that MYBBP1A is required for p53 (zeige TP53 Antikörper) activation during anoikis; therefore, it is involved in suppressing colony formation and the tumorigenesis of breast cancer cells.
May activate or repress transcription via interactions with sequence specific DNA-binding proteins. Repression may be mediated at least in part by histone deacetylase activity (HDAC activity).
MYB binding protein (P160) 1a
, MYB binding protein 1a
, myb-binding protein 1A-like
, myb-binding protein 1A
, myb-binding protein of 160 kDa
, nuclear protein P160
, MYB binding protein 1a
, PAR interacting protein
, PAR-interacting protein
, p53-activated protein-2
, myb-binding protein 1A-like protein